JPL Wealth Management »

Keros Therapeutics shares owned by JPL Wealth Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by JPL Wealth Management from 13F filings

Historical chart of JPL Wealth Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by JPL Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by JPL Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $132 12 11.08

More positions owned by JPL Wealth Management

Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Spdr Series Trust State Street Spd (SPYM)
Apple (AAPL)
Broadcom (AVGO)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ea Series Trust Alpha Architect (CAOS)
Alphabet Cap Stk Cl A (GOOGL)
Ea Series Trust Alpha Architect (AAEQ)
UnitedHealth (UNH)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Chevron Corporation (CVX)
Caterpillar (CAT)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)

View all positions for JPL Wealth Management

Top funds holding Keros Therapeutics

BlackRock
Vanguard Group
Nantahala Capital Management
Arrowstreet Capital, Limited Partnership
State Street Corporation
Vanguard Capital Management
Madison Avenue Partners
Qube Research & Technologies
OrbiMed Advisors
Jacobs Levy Equity Management
Federated Investors
Vanguard Portfolio Management
Geode Capital Management
Renaissance Technologies
Citadel Advisors

View all funds holding Keros Therapeutics